YOLFTbeta
Apotea

Apotea

APOTEA · ST · Healthcare / Pharmaceutical Retailers

100.40SEK+0.60 (+0.60%)

Price History

Full chart

Market Stats

Previous Close99.80
Open99.00
Day Range98.75 – 100.90
52-Week Range54.00 – 93.96
Volume206.78K
Market Cap8.54B
P/E (TTM)34.77
Forward P/E0.00
EPS2.36
Dividend Yield0.72%
50-Day Avg76.39
200-Day Avg71.94

About

Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and drink, mouth and teeth, premium, trip, sex and lust, stop smoking, makeup, sun protection, wounds and injuries, sleep and sleep problems, training, weight control, vitamins and minerals, charity, and eyes and ears. In addition, the company offers leasing and hiring out personnel to related companies, as well as marketing contributions. The company was founded in 2011 and is headquartered in Stockholm, Sweden.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Par Svardson
  • Employees736
  • HeadquartersSveavägen 168, Stockholm, Sweden, 113 46, Sweden
  • Websitehttps://www.apotea.se

Leadership

  • Mr. Par SvardsonFounder, MD, CEO & Director · b. 1969
  • Ms. Sarah AhnstromDeputy CEO & COO · b. 1989
  • Mr. Stefan ErikssonVice President of Organization and Personnel & IR Manager · b. 1970
  • Ms. Joanna HummelChief Growth Officer · b. 1975
  • Mr. Johan MarildChief Financial Officer · b. 1982

Financials

Income Statement

Currency: SEK2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.56B4.88B5.45B6.54B7.20B
Growth (%)-+7.04%+11.62%+20.02%+10.12%
Cost of Revenue3.81B3.61B4.00B4.75B5.27B
Gross Profit750.33M1.27B1.45B1.79B1.94B
Gross Margin16.45%26.04%26.58%27.34%26.90%
Operating Expense616.76M1.22B1.34B1.53B1.63B
Operating Income133.57M49.00M112.70M262.80M303.70M
Operating Margin2.93%1.00%2.07%4.02%4.22%
EBITDA160.27M104.80M226.00M399.60M464.10M
EBITDA Margin3.51%2.15%4.15%6.11%6.44%
Net Income104.49M19.90M87.00M214.90M228.70M
Net Income Margin2.29%0.41%1.60%3.29%3.17%
R&D597.63K----
R&D as % of Total Revenue0.01%----
Interest Expense-3.80M4.60M5.30M12.00M
Interest Expense % of Total Revenue-0.08%0.08%0.08%0.17%

Balance Sheet

Currency: SEK2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.02B1.25B132.18M146.49M1.98B
Total Liabilities684.99M897.50M90.14M89.25M1.12B
Total Equity339.76M327.50M39.93M55.37M844.00M
Cash81.38M18.20M1.89M2.46M3.31M
Total Debt144.33M332.70M25.89M21.78M331.00M
Net Debt62.95M314.50M24.00M19.32M327.69M

Cash Flow

Currency: SEK2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow227.30M31.50M215.80M206.20M333.30M
Investing Cash Flow-81.58M-141.40M-121.60M-163.70M-214.50M
Financing Cash Flow-78.39M46.30M-93.30M-34.20M-115.30M
Capital Expenditure81.48M142.10M121.10M163.80M215.60M
Free Cash Flow145.82M-110.60M94.70M42.40M117.70M
Dividends Paid28.39M28.50M---
FCF to OCF64.15%-351.11%43.88%20.56%35.31%
Dividend Paid to FCF19.47%-25.77%---

Earnings

Report DateFeb 6, 2025May 8, 2025Jul 18, 2025Nov 6, 2025Feb 4, 2026Apr 29, 2026Jul 17, 2026Nov 5, 2026
EPS Estimate-0.53-0.580.370.550.720.72
EPS Actual0.470.690.690.670.150.760.78-
Surprise-30.19%-15.52%-59.46%38.18%8.33%-
Timing-Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap8.54B
Enterprise Value8.70B
Trailing P/E34.77
Forward P/E0.00
Price / Sales1.13
Price / Book9.00
EPS2.36
Book Value9.10
Revenue (TTM)7.59B
Gross Profit (TTM)1.51B
EBITDA452.10M
Profit Margin3.24%
Operating Margin5.15%
Return on Equity27.84%
Return on Assets9.45%
Shares Outstanding104.07M
Shares Float65.98M
Dividend Yield0.72%
Dividend Rate0.60
Payout Ratio25.42%

Dividends

20261×
0.60May 27, 2026